The Microplastics Safety Act directs the Food and Drug Administration to study how microplastics—tiny plastic particles found in food and water—affect human health. The study must examine how people are exposed to microplastics and their potential impacts on children, the endocrine system, cancer risk, chronic illness, and reproductive health. Within one year of the bill's enactment, the FDA must report its findings and recommendations to Congress on what legislative or administrative actions might be needed to address these health concerns. The bill does not specify funding amounts but requires the FDA to conduct the research and provide Congress with actionable recommendations based on the study results.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.